Friday, 9 April 2021

NIH begins study of allergic reactions to Moderna, Pfizer-BioNTech COVID-19 vaccines

NIH begins study of allergic reactions to Moderna, Pfizer-BioNTech COVID-19 vaccines
NIH begins study of allergic reactions to Moderna, Pfizer-BioNTech COVID-19 vaccines

A clinical trial is underway to determine whether people who are highly allergic or have a mast cell disorder are at increased risk for an immediate, systemic allergic reaction to the Moderna or Pfizer-BioNTech COVID-19 vaccines. A systemic allergic reaction to a vaccine occurs in one or more parts of the body beyond the injection site.

admin Fri, 04/09/2021 - 16:31

source https://www.pharmatutor.org/pharma-news/2021/nih-begins-study-of-allergic-reactions-to-moderna-pfizer-biontech-covid-19-vaccines

No comments:

Post a Comment

Pharmaceutical Industry and pharma / Life Sciences institute openings 2025

  Intas Pharma Walk in Drive for M.Pharm, B.Pharm | Multiple Posts M.Pharma / B.Pharma. Injectable/Parenteral/Sterile - Aseptic, Manufacturi...